126 related articles for article (PubMed ID: 26259531)
21. Mutation and expression of a methyl-binding protein 6 (MBD6) in gastric and colorectal cancers.
Choi YJ; Yoo NJ; Lee SH
Pathol Oncol Res; 2015 Jul; 21(3):857-8. PubMed ID: 25638327
[No Abstract] [Full Text] [Related]
22. Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.
Hnízda A; Škerlová J; Fábry M; Pachl P; Šinalová M; Vrzal L; Man P; Novák P; Řezáčová P; Veverka V
BMC Biol; 2016 Oct; 14(1):91. PubMed ID: 27756303
[TBL] [Abstract][Full Text] [Related]
23. What does over-expression of cN-II enzyme signify in haematological malignancies?
Galmarini CM
Leuk Res; 2007 Oct; 31(10):1325-6. PubMed ID: 17434583
[No Abstract] [Full Text] [Related]
24. Somatic mutations in long-non-coding RNA RMRP in acute leukemias.
Son HJ; Choi EJ; Yoo NJ; Lee SH
Pathol Res Pract; 2019 Nov; 215(11):152647. PubMed ID: 31564567
[No Abstract] [Full Text] [Related]
25. NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.
Elsaid MF; Ibrahim K; Chalhoub N; Elsotouhy A; El Mudehki N; Abdel Aleem A
BMC Med Genet; 2017 Mar; 18(1):33. PubMed ID: 28327087
[TBL] [Abstract][Full Text] [Related]
26. Frameshift mutation of an angiogenesis factor VEGFB and its mutational heterogeneity in colorectal cancers.
Choi MR; Yoo NJ; Lee SH; An CH
Pathol Oncol Res; 2015 Jul; 21(3):853-5. PubMed ID: 25633991
[No Abstract] [Full Text] [Related]
27. p53 gene mutation in recurrent superficial bladder cancer.
Yoshimura I; Kudoh J; Saito S; Tazaki H; Shimizu N
J Urol; 1995 May; 153(5):1711-5. PubMed ID: 7715016
[TBL] [Abstract][Full Text] [Related]
28. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
29. Sequence conservation of RAG-1 and RAG-2 genes in hematologic malignancies.
Mulero MC; Estivill C; Corral J; Sierra J; Baiget M; Nomdedéu JF
Leukemia; 2002 Aug; 16(8):1571. PubMed ID: 12145704
[No Abstract] [Full Text] [Related]
30. GNAS mutation affecting codon 201 is rare in most human tumors.
Je EM; An CH; Chung YJ; Yoo NJ; Lee SH
Pathol Oncol Res; 2015 Jul; 21(3):859-60. PubMed ID: 25740075
[No Abstract] [Full Text] [Related]
31. Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase.
Falk IJ; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
Am J Hematol; 2013 Dec; 88(12):1001-6. PubMed ID: 23873772
[TBL] [Abstract][Full Text] [Related]
32. Analysis of promoter mutation in CTNNB1 gene in solid and hematologic neoplasia.
Mo HY; An CH; Choi EJ; Yoo NJ
Pathol Res Pract; 2019 Nov; 215(11):152673. PubMed ID: 31587824
[No Abstract] [Full Text] [Related]
33. Minimal residual disease testing in hematologic malignancies and solid cancer.
Ben Lassoued A; Nivaggioni V; Gabert J
Expert Rev Mol Diagn; 2014 Jul; 14(6):699-712. PubMed ID: 24938122
[TBL] [Abstract][Full Text] [Related]
34. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
35. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
36. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
37. New Prognostic and Predictive Markers in Head and Neck Tumors.
Cantile M; Longo F; Botti G; Fulciniti F
Biomed Res Int; 2016; 2016():2850502. PubMed ID: 26989680
[No Abstract] [Full Text] [Related]
38. EGFR Mutation Genotype Impact on the Efficacy of Pemetrexed in Patients with Nonsquamous Nonsmall Cell Lung Cancer.
Igawa S; Sato Y; Ishihara M; Kasajima M; Kusuhara S; Nakahara Y; Otani S; Fukui T; Katagiri M; Sasaki J; Masuda N
Asian Pac J Cancer Prev; 2016; 17(7):3249-53. PubMed ID: 27509958
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of MYC in common epithelial cancers and acute leukemias.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Jun; 114(6):436-9. PubMed ID: 16856965
[TBL] [Abstract][Full Text] [Related]
40. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
Chang SC; Lin PC; Lin JK; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK
Ann Surg Oncol; 2016 Mar; 23(3):849-55. PubMed ID: 26471487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
